Top Markets
Coin of the day
Dong Sung Bio Pharm.Co.,Ltd. Dong Sung Bio Pharm.Co.,Ltd.

Dong Sung Bio Pharm.Co.,Ltd.

002210
Κατάταξη σε μετοχές #28327
Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations... Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations spanning pharmaceuticals, cosmetics, hair dye manufacturing, and photodynamic therapy. Its extensive product range includes a broad selection of over-the-counter (OTC) medications designed to treat a variety of conditions. These encompass liver ailments, menopausal symptoms, skin disorders, obesity, digestive and gum health issues, and hair loss. The company's OTC offerings also feature remedies for fever, pain, inflammation, respiratory illnesses, scar reduction, and sleep disturbances, along with antiviral, anti-diarrhea, anti-nausea, blood circulation enhancing, antifungal, and antihistamine drugs. Supplementary OTC products include keratin softeners, eye nutrition supplements, and essential vitamins. Furthermore, Dong Sung Bio Pharm produces ethical (prescription-only, or ETC) drugs. These target specific medical areas such as endocrine, gastrointestinal, circulatory, neuropsychological, and oncological conditions. Its ETC portfolio also contains analgesic and anti-inflammatory agents, dermato-urinary treatments, antiviral, antibiotic, antifungal, and antihistamine medications, as well as respiratory drugs, steroids, and ophthalmic drops. Beyond its pharmaceutical lines, the company offers a range of consumer health and personal care items. These include hair coloring products, functional health foods, medical devices, various daily necessities, muscle taping supplies, disinfectants, toothpastes, shampoos for anti-hair loss and hair growth, and sanitary pads. Dong Sung Bio Pharm.Co.,Ltd. was founded in 1957 and maintains its headquarters in Seoul, South Korea.
Τιμή μετοχής
$1.11
Κεφαλαιοποίηση
$27.12M
Αλλαγή (1 ημέρα)
0.00%
Αλλαγή (1 έτος)
57.93%
Χώρα
KR
Εμπόριο Dong Sung Bio Pharm.Co.,Ltd. (002210)

Κατηγορία

Κέρδη για την Dong Sung Bio Pharm.Co.,Ltd. (002210)
Κέρδη τον Mar 2026 TTM: $-18.85M
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της Dong Sung Bio Pharm.Co.,Ltd., τα τρέχοντα κέρδη της εταιρείας είναι $-18.85M. Το 2023, η εταιρεία παρουσίασε κέρδη $-668.88K, αύξηση σε σχέση με των κερδών του 2022 που ήταν $-1.47M. Τα κέρδη που εμφανίζονται σε αυτή τη σελίδα είναι πριν από τόκους και φόρους, γνωστά και ως EBIT.
Ιστορικό κερδών για την Dong Sung Bio Pharm.Co.,Ltd. από 2007 έως 2026
Κέρδη στο τέλος κάθε έτους
Έτος Κέρδη Αλλαγή
2026 (TTM) $-18.85M 261.93%
2024 $-5.21M 678.53%
2023 $-668.88K -54.39%
2022 $-1.47M -60.19%
2021 $-3.68M -62.99%
2020 $-9.95M 31.12%
2019 $-7.59M 26.29%
2018 $-6.01M 1,031.31%
2017 $-531.32K -74.81%
2016 $-2.11M -433.12%
2015 $633.14K -123.13%
2014 $-2.74M -7.49%
2013 $-2.96M -187.69%
2012 $3.37M 123.65%
2011 $1.51M -133.49%
2010 $-4.50M -873.29%
2009 $582.51K -85.64%
2008 $4.06M 9.40%
2007 $3.71M 0.00%
Κέρδη παρόμοιων εταιρειών ή ανταγωνιστών